We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+11.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.06B
AUM Growth
+$153M
Cap. Flow
+$77M
Cap. Flow %
7.28%
Top 10 Hldgs %
8.36%
Holding
708
New
178
Increased
217
Reduced
190
Closed
93

Top Buys

Rank Stock Value
1
VLTO icon
Veralto
VLTO
+$4.25M
2
MTB icon
M&T Bank
MTB
+$4.04M
3
BJ icon
BJs Wholesale Club
BJ
+$3.86M
4
RCI icon
Rogers Communications
RCI
+$3.84M
5
INTC icon
Intel
INTC
+$3.84M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$53.1M
2
STLA icon
Stellantis
STLA
+$8.81M
3
HUBB icon
Hubbell
HUBB
+$4.16M
4
AMAT icon
Applied Materials
AMAT
+$3.47M
5
DOCN icon
DigitalOcean
DOCN
+$3.46M

Sector Composition

Rank Sector Weight
1 Technology 22.82%
2 Healthcare 18.21%
3 Industrials 14.27%
4 Consumer Discretionary 12.02%
5 Financials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNST icon
601
The Honest Company
HNST
$412M
$106K 0.01%
+26,292
New +$88.7K
OOMA icon
602
Ooma
OOMA
$601M
$106K 0.01%
12,382
+813
+7% +$8.09K
CMBM
603
DELISTED
Cambium Networks
CMBM
$103K 0.01%
+23,929
New +$108K
STKS icon
604
The ONE Group
STKS
$55.9M
$101K 0.01%
18,156
+7,200
+66% +$31.5K
INGN icon
605
Inogen
INGN
$174M
$98.8K 0.01%
12,243
-31,632
-72% -$224K
GLUE icon
606
Monte Rosa Therapeutics
GLUE
$1.82B
$98.4K 0.01%
+13,955
New +$82.8K
GTHX
607
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$96.7K 0.01%
+22,387
New +$78K
AMPY icon
608
Amplify Energy
AMPY
$158M
$90K 0.01%
+13,619
New +$82.8K
MFIN icon
609
Medallion Financial
MFIN
$230M
$86.2K 0.01%
+10,896
New +$97.9K
GILT icon
610
Gilat Satellite Networks
GILT
$789M
$85.6K 0.01%
15,766
WVE icon
611
Wave Life Sciences
WVE
$1.12B
$82.1K 0.01%
+13,300
New +$66.6K
DIBS icon
612
1stdibs.com
DIBS
$148M
$76.4K 0.01%
+12,827
New +$65.2K
RSKD icon
613
Riskified
RSKD
$719M
$75.7K 0.01%
+14,001
New +$66.5K
RLMD icon
614
Relmada Therapeutics
RLMD
$540M
$75.5K 0.01%
16,227
+1,307
+9% +$6.3K
OPRT icon
615
Oportun Financial
OPRT
$262M
$71.1K 0.01%
29,271
+6,291
+27% +$22.7K
ABG icon
616
Asbury Automotive
ABG
$4.62B
-11,080
Closed -$2.49M
ACAD icon
617
Acadia Pharmaceuticals
ACAD
$4.51B
-13,599
Closed -$426K
AG icon
618
First Majestic Silver
AG
$7.52B
-348,291
Closed -$2.14M
AGRO icon
619
Adecoagro
AGRO
$1.4B
-22,934
Closed -$255K
AIRS icon
620
AirSculpt Technologies
AIRS
$308M
-11,565
Closed -$86.6K
ALNY icon
621
Alnylam Pharmaceuticals
ALNY
$38.3B
-5,916
Closed -$1.13M
AMGN icon
622
Amgen
AMGN
$209B
-2,400
Closed -$691K
APP icon
623
Applovin
APP
$134B
-35,490
Closed -$1.41M
ATMU icon
624
Atmus Filtration Technologies
ATMU
$4.12B
-24,917
Closed -$585K
AVD icon
625
American Vanguard Corp
AVD
$68.7M
-36,885
Closed -$405K

Similar funds

PDT Partners's Q1 2024 Portfolio in Review

As of Q1 2024, PDT Partners held 708 positions worth $1.06B, up 17% from $905M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

PDT Partners deployed $77M of net new capital in Q1 2024, opening 178 new positions and adding to 217 existing holdings. Its largest new stake was Veralto: 51,311 shares worth $4.55M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Ferrari, an estimated $53.1M trimmed.

  • PDT Partners's largest Q1 2024 buy was Veralto: 51,311 shares worth $4.55M.
  • PDT Partners added most to BJs Wholesale Club in Q1 2024, an estimated $3.86M increase.
  • PDT Partners's biggest Q1 2024 reduction was Ferrari, cutting an estimated $53.1M.
  • PDT Partners fully exited Royalty Pharma in Q1 2024, selling an estimated $3.4M.
  • PDT Partners's ten largest holdings make up 8.4% of its $1.06B portfolio in Q1 2024.
  • PDT Partners opened 178 new positions and closed 93 in Q1 2024.
  • PDT Partners's portfolio value rose 17% quarter-over-quarter to $1.06B.

Based on PDT Partners's 13F filing for Q1 2024, filed 15 May 2024.